Akrotome Imaging, Inc.
Our technology supports visualization of malignant tumors inter-operatively, targeting unmet medical needs in the $2B guided-surgery market.
Akrotome focuses on the translation of core research into new approaches to clinical practice and standards of care, reducing costs, enhancing quality of life for patients, and improving outcomes. Our patented molecular probes bind to proteases produced by cancers, making them glow brightly in near-infrared light. Our first product reduces repeat lumpectomy surgeries by 90%. We target clinicians and financial managers in top cancer centers.